Clinical Trial: Supersaturated Hydrogen-Rich Water for Outpatients With Persistent Excess Weight

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07410065) titled 'Supersaturated Hydrogen-Rich Water for Outpatients With Persistent Excess Weight' on Feb. 07.

Brief Summary: The Supersaturated Hydrogen-Rich Water for Outpatients with Persistent Excess Weight (HOPE) study is a Phase III, multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of daily consumption of supersaturated hydrogen-rich water in adults with persistent excess body weight. The trial investigates whether sustained exposure to molecular hydrogen can favorably influence body composition and key metabolic outcomes compared with a placebo water lacking dissolved hydrogen. By en...